Evidence map›Paper›PMID 41256823›Full record

ReviewJournal of clinical practice and research2024

Diagnosing Tuberculosis: Traditional and New Methods Against an Old Enemy.

Gönül Aslan

Abstract readReview
In one paragraph

Review in Journal of clinical practice and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gönül AslanDepartment of Medical Microbiology, Mersin University Faculty of Medicine, Mersin, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) poses significant health challenges globally, contributing significantly to illness and mortality. Approximately one-fourth of the world's population is believed to carry the tuberculosis bacterium, with a 5-10% lifetime risk of developing active TB disease. Timely identification of TB and rapid detection of drug resistance are crucial in mitigating its global impact. Clinical, radiological, bacteriological, and molecular methods are used to screen and diagnose TB. Microscopy, culture, and immunological methods are commonly employed. Although microscopy has been used for approximately a century, it has limitations, necessitating its use and evaluation alongside other diagnostic techniques for a complete and accurate diagnosis. Bacterial culture in solid and liquid media is still the gold standard recommended by the World Health Organization (WHO) for the diagnosis of TB, as it enables the isolation of

Indexed as

DiagnosislaboratoryMycobacterium tuberculosistraditional and new methodstuberculosis

Identifiers

PMID41256823
PMCPMC12478684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.